SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is gaining attention as the community rallies around the revival of OG meme culture and the iconic Rage Guy comics. Discussions center on community building and shared experiences, with members emphasizing unity and resilience. The focus is on establishing a strong cultural movement within the memecoin space, moving beyond fleeting trends.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following a mixed reaction to earnings, with a revenue beat offset by lowered guidance due to data center delays, sparking debate about its growth trajectory. The community is weighing the significance of a massive backlog and key partnerships against concerns over profitability and debt. Analyst upgrades are adding fuel to the discussion, with some seeing a buying opportunity in the AI infrastructure play.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

$AVXL is trending as investors await potential news from the upcoming CHMP meeting regarding Anavex's Alzheimer's drug, Blarcamesine. Community discussions revolve around the possibility of conditional approval, the drug's safety profile, and its potential impact on the Alzheimer's treatment landscape. Some traders are also weighing the technical indicators, noting the stock's oversold condition and potential for a short-term rebound.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai (BBAI) is trending following its Q3 earnings release and announcement to acquire Ask Sage, a generative AI platform, driving optimism about future growth and expansion into the defense sector. The community is focused on the potential impact of Ask Sage, particularly its existing government contracts and potential for cross-selling opportunities. Despite revenue declines, the acquisition and potential for government contracts are fueling speculation about a potential turnaround, with some drawing comparisons to Palantir (PLTR).

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending amid ongoing speculation about a potential acquisition of Warner Bros. Discovery, with community discussions focusing on the terms of the deal and potential synergies. Recent earnings and cost-cutting measures are also key talking points, as investors assess the company's financial health and future direction under new management.

Veterans Recognition Currency

Veterans Recognition Currency ($VETERANS) is gaining attention as the community focuses on its chart strength and Phantom availability. The project's mission to support veterans and recent donations are sparking positive sentiment. However, some users are raising concerns and scam allegations about the project, creating a divided discussion.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto Inc. ($GLTO) is trending due to a massive surge following the acquisition of Damora Therapeutics and a significant funding round, shifting its focus to hematologic malignancies. The community is discussing the potential for a short squeeze given the low float and high cost to borrow, while also noting technical indicators suggesting it may be overbought. Traders are watching for potential multi-day continuation, with some speculating on price targets, while others caution about potential pullbacks.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap ($UNI) is trending as the community anticipates a potential fee switch activation, which could redirect trading fees to UNI holders. Positive sentiment is fueled by discussions around Uniswap's strong fundamentals and increasing fee generation, with some speculating on potential price targets. The broader DeFi sector and Uniswap's role within it are also contributing to the heightened interest.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk ($SNDK) is trending due to a mix of factors, including increased demand for storage devices in data centers and AI applications, leading to significant price increases and supply shortages. The stock's parabolic rise has sparked discussions about a potential short squeeze and whether it's overvalued, with some traders noting its historical volatility and connection to the broader memory and storage sector, including companies like $MU and $WDC.

Memecoin on Injective taken over by the community.

Nonja

$NONJA is trending due to growing excitement around Injective's ecosystem, with discussions focusing on its strong community, unique NFTs, and potential for high returns. The community highlights its strong chart and burned liquidity, creating excitement for potential gains as $INJ gains traction and a possible ETF approval looms. Many community members are very bullish on the project's long term potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder

Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with...

Pier 88 Investment Partners LLC Sells 3,680 Shares of Neurocrine Biosciences, Inc. $NBIX

Pier 88 Investment Partners LLC cut its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 43.0% in the 2nd quarter, according to its most recent Form 13F filing with the...

Neurocrine Biosciences, Inc. $NBIX Stock Holdings Increased by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC grew its stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 19,454.9% during the 2nd quarter, according to the company in its most...

William Rastetter Sells 18,000 Shares of Neurocrine Biosciences (NASDAQ:NBIX) Stock

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director William Rastetter sold 18,000 shares of the business's stock in a transaction that occurred on Wednesday, November 5th. The...

Neurocrine Biosciences (NASDAQ:NBIX) Director William Rastetter Sells 18,000 Shares

Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Get Free Report) Director William Rastetter sold 18,000 shares of the firm's stock in a transaction on Wednesday, November 5th. The shares were sold at an...

C WorldWide Group Holding A S Acquires 20,000 Shares of Neurocrine Biosciences, Inc. $NBIX

C WorldWide Group Holding A S raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX - Free Report) by 17.4% in the 2nd quarter, according to the company in its most recent Form...

Earnings Estimates Rising for Neurocrine (NBIX): Will It Gain?

Neurocrine Biosciences (NBIX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Neurocrine Biosciences (NASDAQ:NBIX) Sets New 52-Week High - Should You Buy?

Neurocrine Biosciences (NASDAQ:NBIX) Hits New 1-Year High - Still a Buy...

What Makes Neurocrine (NBIX) a New Strong Buy Stock

Neurocrine (NBIX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus

XENE reports narrower-than-expected Q3 loss as the biotech advances multiple late-stage studies of azetukalner across epilepsy and mood disorders.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

$NVDA

$MSFT

$AAPL

$GOOGL

Which of these Mag 7 stocks are you most bullish on right now?

Current Price	$150.02
Prev Close	$152.37
Open	$152.97
Dividend Yield	0.00%
50-Day Moving Average	$142.23
Beta	0.68
Avg. Volume	933,591.91
PE Ratio	35.83

52-Week High	$157.67
52-Week Low	$84.23
Market Capitalization	$15.19B
EPS (Annual)	$3.29
Price to Book	4.98
Revenue Per Employee	$1.31M
Enterprise Value/EBITDA	N/A

NBIX
Neurocrine Biosciences, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NBIX News

NBIXNeurocrine Biosciences, Inc.